Seoul, South Korea

Chang Hyun Oh

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 1.6

ph-index = 7

Forward Citations = 131(Granted Patents)


Location History:

  • Kyung Ki Do, KR (1987)
  • Seoul, KR (1985 - 2022)

Company Filing History:


Years Active: 1985-2022

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Chang Hyun Oh: Innovator in Antitumor Pharmaceutical Compositions

Introduction

Chang Hyun Oh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds with antitumor effects. With a total of 16 patents to his name, his work has the potential to impact cancer treatment significantly.

Latest Patents

One of Chang Hyun Oh's latest patents is an imidazooxazole derivative that exhibits antitumor effects. This pharmaceutical composition is designed for preventing and treating tumors. It includes an imidazooxazole derivative compound, a solvate, a stereoisomer, or a pharmaceutically acceptable salt as an active ingredient. The composition is administered to individuals who have developed a tumor or are at risk of developing one, thereby providing a means to prevent or treat tumors effectively.

Career Highlights

Throughout his career, Chang Hyun Oh has worked with notable organizations, including J & L Importers, Inc. and the Korea Institute of Science and Technology. His experience in these institutions has allowed him to refine his research and development skills, contributing to his success as an inventor.

Collaborations

Chang Hyun Oh has collaborated with several professionals in his field, including Kyung Ho Yoo and Tae Bo Sim. These collaborations have likely enhanced his research and led to innovative solutions in pharmaceutical development.

Conclusion

Chang Hyun Oh stands out as a significant figure in the realm of pharmaceutical innovation, particularly in the development of antitumor agents. His contributions through patents and collaborations continue to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…